| Literature DB >> 31059209 |
Anna H Hakonen1, Anne Polvi1,2, Carola Saloranta1,3, Anders Paetau4, Päivi Heikkilä4, Henrikki Almusa2, Pekka Ellonen2, Eveliina Jakkula1, Janna Saarela2, Kristiina Aittomäki1.
Abstract
Fetal akinesia deformation sequence (FADS) and lethal multiple pterygium syndrome (LMPS) are clinically overlapping syndromes manifesting with reduced or absent fetal movement, arthrogryposis, and several anomalies during fetal life. The etiology of these syndromes is heterogeneous, and in many cases it remains unknown. In order to determine the genetic etiology of FADS in two fetuses with fetal akinesia, arthrogryposis, edema, and partial cleft palate, we utilized exome sequencing. Our investigations revealed a homozygous nonsense variant [c.1116C>A, p.(Cys372Ter)] in the SLC18A3 gene, which encodes for the vesicular acetylcholine transporter (VAChT) responsible for active transport of acetylcholine in the neuromuscular junction. This is the first description of a nonsense variant in the SLC18A3 gene, as only missense variants and whole gene deletions have been previously identified in patients. The previously detected SLC18A3 defects have been associated with congenital myasthenic syndromes, and therefore our findings extend the clinical spectrum of SLC18A3 defects to severe prenatal phenotypes. Our findings suggest that nonsense variants in SLC18A3 cause a more severe phenotype than missense variants and are in line with previous studies showing a lethal phenotype in VAChT knockout mice. Our results underline the importance of including SLC18A3 sequencing in the differential diagnostics of fetuses with arthrogryposis, FADS, or LMPS of unknown etiology.Entities:
Keywords: zzm321990SLC18A3; arthrogryposis; fetal akinesia deformation sequence; multiple pterygium syndrome; vesicular acetylcholine transporter
Mesh:
Substances:
Year: 2019 PMID: 31059209 DOI: 10.1002/ajmg.a.61186
Source DB: PubMed Journal: Am J Med Genet A ISSN: 1552-4825 Impact factor: 2.802